Artificial intelligence in peptide-based drug design.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Artificial intelligence in peptide-based drug design.
- Published In:
- Drug discovery today, 30(2), 104300 (2025)
- Authors:
- Zhai, Silong, Liu, Tiantao, Lin, Shaolong, Li, Dan, Liu, Huanxiang, Yao, Xiaojun, Hou, Tingjun
- Database ID:
- RPEP-14472
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14472APA
Zhai, Silong; Liu, Tiantao; Lin, Shaolong; Li, Dan; Liu, Huanxiang; Yao, Xiaojun; Hou, Tingjun. (2025). Artificial intelligence in peptide-based drug design.. Drug discovery today, 30(2), 104300. https://doi.org/10.1016/j.drudis.2025.104300
MLA
Zhai, Silong, et al. "Artificial intelligence in peptide-based drug design.." Drug discovery today, 2025. https://doi.org/10.1016/j.drudis.2025.104300
RethinkPeptides
RethinkPeptides Research Database. "Artificial intelligence in peptide-based drug design." RPEP-14472. Retrieved from https://rethinkpeptides.com/research/zhai-2025-artificial-intelligence-in-peptidebased
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.